Papp L Roy & Associates Bristol Myers Squibb CO Transaction History

Papp L Roy & Associates

$820 Million
Q3 2024

A detailed history of Papp L Roy & Associates transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Papp L Roy & Associates holds 10,084 shares of BMY stock, worth $573,174. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,084

Previous 11,184 9.84%

Holding current value

$573,174

Previous $464,000 12.28%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $43,625 - $56,925	-1,100 Reduced 9.84%	10,084 $521,000
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $7,395 - $8,757	-108 Reduced 0.96%	11,184 $0
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $870 - $514,520	-6,696 Reduced 37.22%	11,292 $803,000
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $7,842 - $8,637	108 Added 0.6%	17,988 $1.39 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $60,742 - $72,835	988 Added 5.85%	17,880 $1.31 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $1,072 - $1,250	20 Added 0.12%	16,892 $1.05 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $11,834 - $13,862	-200 Reduced 1.17%	16,872 $998,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $74,292 - $80,904	1,200 Added 7.56%	17,072 $1.14 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $72,928 - $82,023	-1,229 Reduced 7.19%	15,872 $1 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $172,700 - $195,701	-2,991 Reduced 14.89%	17,101 $1.06 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $51,112 - $56,639	-890 Reduced 4.24%	20,092 $1.21 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $493 - $576	9 Added 0.04%	20,982 $1.23 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $3,016 - $4,382	65 Added 0.31%	20,973 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $835,241 - $1.09 Million	16,973 Added 431.33%	20,908 $1.34 Million
Q3 2019 Nov 04, 2019	BUY	$42.77 - $50.71 $168,299 - $199,543	3,935 New	3,935 $200,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $278,205 - $307,634	-6,235 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $29,140 - $32,868	-528 Reduced 7.81%	6,235 $387,000
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $40,322 - $50,258	-798 Reduced 10.55%	6,763 $374,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $36,491 - $42,008	609 Added 8.76%	7,561 $478,000
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $2,577 - $2,810	43 Added 0.62%	6,952 $426,000
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $381,584 - $440,379	6,909	6,909 $440,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Bristol Myers Squibb CO Transaction History